These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers. Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252 [TBL] [Abstract][Full Text] [Related]
23. Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study. Hicken BL; Sharara AI; Abrams GA; Eloubeidi M; Fallon MB; Arguedas MR Aliment Pharmacol Ther; 2003 Jan; 17(1):145-53. PubMed ID: 12492744 [TBL] [Abstract][Full Text] [Related]
24. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis. Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226 [TBL] [Abstract][Full Text] [Related]
25. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study. Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421 [TBL] [Abstract][Full Text] [Related]
26. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study. Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436 [TBL] [Abstract][Full Text] [Related]
27. The clinical use of HVPG measurements in chronic liver disease. Bosch J; Abraldes JG; Berzigotti A; García-Pagan JC Nat Rev Gastroenterol Hepatol; 2009 Oct; 6(10):573-82. PubMed ID: 19724251 [TBL] [Abstract][Full Text] [Related]
28. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Albillos A; Bañares R; González M; Ripoll C; Gonzalez R; Catalina MV; Molinero LM Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317 [TBL] [Abstract][Full Text] [Related]
29. A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis. Wang T; Liang F; Zhou Z; Shi L J Biomech; 2017 Dec; 65():23-31. PubMed ID: 29042056 [TBL] [Abstract][Full Text] [Related]
30. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea]. Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762 [TBL] [Abstract][Full Text] [Related]
31. Preventing the development of varices in cirrhosis. Garcia-Tsao G J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480 [TBL] [Abstract][Full Text] [Related]
32. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension. Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126 [TBL] [Abstract][Full Text] [Related]
33. Measurement of portal pressure: when, how, and why to do it. Groszmann R; Vorobioff JD; Gao H Clin Liver Dis; 2006 Aug; 10(3):499-512, viii. PubMed ID: 17162225 [TBL] [Abstract][Full Text] [Related]
34. [Analysis of 833 times measured hepatic venous pressure gradient]. Zhang MY; Wang GC; Huang GJ; Feng H; Wang LF; Zhang JY; Shi YJ; Zhang CQ Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):266-270. PubMed ID: 29996337 [No Abstract] [Full Text] [Related]